Elevated levels of Ang-2 and a higher Ang-2/Ang-1 ratio have been reported in patients with CM, as have other markers of endothelial activation including sICAM-1 and vWF [18]–[24], [54]. This evidence concerns the gene ANGPT2 and cutaneous mastocytosis.